Sendas Distribuidora (ASAI3) Institutional Presentation summary
Event summary combining transcript, slides, and related documents.
Institutional Presentation summary
10 Apr, 2026Market position and brand value
Handles approximately 40 million customer visits monthly, with 60% household penetration in Greater São Paulo.
Recognized as the most valuable retail brand in Brazil, valued at R$12 billion.
Largest and most present food retail company in the country.
Maintains a diverse customer base, serving both B2C and B2B segments across all social classes.
Operates in a highly fragmented market, holding a 6–8% share of the food market universe.
Financial performance and growth
Achieved gross revenue of R$85 billion in 2025, up 86% from 2021.
Free cash generation reached R$2.8 billion in 2025, with leverage reduced to 2.56x.
EBITDA margin pre-IFRS16 improved to 5.8% in 2025, with gross margin at 16.8%.
Net debt reduced by R$1.2 billion in 2025, with disciplined capex of R$700 million planned for 2026.
100% of expansion financed by operating cash flow.
Expansion and operational excellence
Expanded to 313 stores in 24 states, with over 1.6 million sqm of sales area and 90,000+ employees.
Opened 140 new stores from 2021–2025, including 66 hypermarket conversions.
Operates multiple store formats, adapting layouts and assortment to regional needs.
Self-checkout operational in 287 stores, processing 20% of tickets and reducing wait times.
Focus on assortment expansion, in-store services, and improved shopping experience.
Latest events from Sendas Distribuidora
- Revenue up 1.7% to R$ 20.6B, stable margins, improved leverage, and strong digital growth.ASAI3
Q1 202629 Apr 2026 - Revenue up 5.2%, EBITDA margin 5.8%, leverage at 2.56x, and free cash flow R$2.8B.ASAI3
Q4 202520 Apr 2026 - Revenue and EBITDA rose as leverage improved, with over 300 stores targeted for 2024.ASAI3
Q2 20241 Feb 2026 - Revenue and EBITDA up, leverage down, and expansion and deleveraging remain priorities.ASAI3
Q3 202415 Jan 2026 - Board size cut, compensation reduced, and new poison pill triggers reflect governance reforms.ASAI3
Status Update26 Dec 2025 - Record revenue, margin gains, and lower leverage defined 2024's strong performance.ASAI3
Q4 202411 Dec 2025 - Revenue up 7.2% and net income up 60% year-over-year, with strong cash flow and lower leverage.ASAI3
Q2 202523 Nov 2025 - Revenue up 7.8%, EBITDA margin at 5.5%, and leverage improved to 3.15x in Q1 2025.ASAI3
Q1 202519 Nov 2025 - Revenue, EBITDA margin, and free cash flow rose as leverage hit a multi-year low.ASAI3
Q3 202513 Nov 2025